Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Eurozone
  • Asset Class: Equity
  • Geographic Focus: Eurozone

Generali Investments SICAV - European SRI Equity

+ Add to Watchlist

GENEDBX:LX

132.34 EUR 2.73 2.02%

As of 01:59:30 ET on 04/20/2015.

Snapshot for Generali Investments SICAV - European SRI Equity (GENEDBX)

Year To Date: +19.85% 3-Month: +14.84% 3-Year: +16.61% 52-Week Range: 99.29 - 136.47
1-Month: +0.22% 1-Year: +23.34% 5-Year: +8.12% Beta vs SXXP: 0.81

Mutual Fund Chart for GENEDBX

No chart data available.
  • GENEDBX:LX 132.34
  • 1M
  • 1Y
Interactive GENEDBX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for GENEDBX

Generali Investments SICAV - European SRI Equity is a SICAV registeredin Luxembourg. The Fund's objective is to provide long-term capital growth and to exceed the performance of the Dow Jones Euro Stoxx 600 Index. The Fund invests principally in actively managed equities of companies which are listed onthe stock exchanges of member countries of the European Monetary Union.

Inception Date: 09-01-2008 Telephone: 352-47-67-6528 Tel
Managers: -
Web Site: www.generali-investments-europe.com

Fundamentals for GENEDBX

NAV (on 2015-04-20) 132.34
Assets (M) (on 2014-12-31) 122.84
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment -

Dividends for GENEDBX

No dividends reported

Fees & Expenses for GENEDBX

Front Load -
Back Load -
Current Mgmt Fee 0.45
Redemption Fee -
12b1 Fee -
Expense Ratio 1.01

Top Fund Holdings for GENEDBX

Filing Date: 01/30/2015
Name Position Value % of Total
Novartis AG 74,970 6,550,113 4.938%
Roche Holding AG 15,000 3,639,288 2.744%
Banco Bilbao Vizcaya Argentari 397,000 3,022,758 2.279%
Siemens AG 31,500 2,948,400 2.223%
Sanofi 35,000 2,879,100 2.171%
Deutsche Telekom AG 170,400 2,639,496 1.990%
Swedbank AB 120,000 2,555,797 1.927%
Fresenius SE & Co KGaA 50,000 2,526,000 1.904%
Telefonica SA 188,200 2,518,116 1.898%
Daimler AG 30,000 2,408,700 1.816%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil